Janus Henderson Group PLC Longboard Pharmaceuticals, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LBPH
# of Institutions
15Shares Held
3.7MCall Options Held
12.3KPut Options Held
13.9K-
Black Rock Inc. New York, NY2.37MShares$142 Million0.0% of portfolio
-
Emerald Mutual Fund Advisers Trust419KShares$25.2 Million0.79% of portfolio
-
Morgan Stanley New York, NY375KShares$22.5 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA114KShares$6.82 Million0.22% of portfolio
-
Readystate Asset Management LP Chicago, IL107KShares$6.44 Million0.07% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $815M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...